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Introduction and Aim 
 
Obesity has become a public global health 
problem. More than 13% of the world’s 7.8 billion 
people (11% of men and 15% of women) are  
obese, defined as having a body mass index above  
30 kg/m2. In North America and several Middle 
Eastern Countries, more than 30% of adults are obese. 
The alarming problem is that children as young as 
twelve years of age are now becoming obese. Obesity 
with high-fat and high-sugar diets is a risk factor  
for type 2 diabetes mellitus (T2DM), hypertension  
and early-onset heart failure (HF) with preserved  
ejection fraction (HFpEF) that leads to frequent 
hospitalizations. It is possible that diet, inactivity and 
other modern lifestyle factors may have an important 
role in the development of heart failure, either with or 
without decrease in ejection fraction [1]. This mini 
review discusses whether circadian oscillations in 
metabolism and inflammation could be responsible 
for the time-of-day-dependence of adverse cardio-
vascular events in patients with HFpEF by increasing 
production of cytotoxic a-dicarbonyl species 
methylglyoxal (MG) and by decreasing expression of 




Review and Conclusion 
 
There is much evidence in the literature that peri-
conceptional, perinatal nutritional factors as well 
dietary fatty acids in later life after birth are important 
in the pathogenesis of cardiovascular diseases  
(CVDs) [2-5]. Increased consumption of saturated, 
monounsaturated or n-6 polyunsaturated fatty acids 
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has also shown beneficial effects in rodent studies [2]. 
This effect is associated with decline in inflammation 
and improved resistance to mitochondrial permea-
bility transition. The underlying mechanisms are 
complex and may be due to cardiac adaptation,  
in particular when diets rich in saturated fat  
are administered. A more thorough knowledge is 
necessary to comprehend the effects of various fatty 
acids on cardiac phospholipids, lipid metabolites  
and metabolic flux in the normal and failing  
heart. Increased intake of high-sugar and high-fat  
diet may cause obesity-induced expression of Glo1 
under inflammatory conditions, which may blunt 
accumulation of MG with circadian clock dysfunction 
of the cardiomyocyte and fibroblast. 
It is proposed that the presence of other nutrients 
such as flavonoids, coenzyme Q10 and -3 fatty acids 
decrease the lipotoxic effects of saturated fat and slow 
the progression of hypertrophy, resulting in HFpEF, 
rather than HFrEF. It is clear that alterations in dietary 
fat intake may have promise in the management of 
HF. The effects of diet on cardiac cells may depend 
on various biomarkers that are known to damage 
cardiomyocytes. Increase in ceramides due to  
high glucose or fast food diets, high levels of 
trimethylamine N-oxide (TAMO) due to increased 
intake of red meat and eggs (choline and lecithin) as 
well as increase in advanced glycation products  
due to high-fat diets are new biomarkers of cardiac 
hypertrophy. These markers should be prevented by 
new therapies, which can avoid the development of 
cardiac hypertrophy as well as HFpEF. Cohort studies 
and animal experiments are needed to determine  
the role of healthy diet in terms of saturated, 
monounsaturated and n-6 polyunsaturated fatty acids 




Figure 1. Modified flow diagram depicting the potential underlying mechanisms of how high-fat and high-glucose diets 
predispose to the development and progression of heart failure. 
Specific pharmacologic agents to treat HFpEF  
are non-existent, in part because it is a diagnosis of 
exclusion, if speckle tracking echocardiography is  
not available. Recent advances in imaging have 
demonstrated that early cardiac dysfunction may be 
identified in a stage of pre-heart failure, which may be 
indicative of HFpEF. Clinical studies targeting  
the renin-angiotensin-aldosterone system (RAAS) to 
attenuate key co-morbidities associated with HFpEF, 
including endothelial cell dysfunction, vascular 
stiffening, impaired myocardial relaxation, fibrosis 
and improved vascular perfusion, have shown only 
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modest decreases in hospitalization rates and adverse 
clinical outcomes, suggesting that activation of RAAS 
may not be a primary cause. The severity of adverse 
cardiovascular events in patients with HFpEF exhibits 
a time-of-day-dependence. It is possible that circadian 
oscillations in metabolism and inflammation could  
be responsible for the time-of-day-dependence of 
adverse cardiovascular events in patients with HFpEF 
by increased circadian production of cytotoxic a-
dicarbonyl species methylglyoxal (MG) and by 
decreasing expression of the primary MG-degrading 
enzyme glyoxalase-1 (Glo1), respectively. It is  
clear that any antioxidant agent such as higher intake 
of omega-3 and monounsaturated fatty acids and 
flavonoids administered as chronotherapy may 
enhance Glo1 release, leading to decline in MG and 
improvement in cardiac function. 
In brief, it is possible that an increase in the 
expression of Glo1 under inflammatory conditions 
may blunt accumulation of MG and reset the 
circadian clock function of the cardiomyocyte and 
fibroblast, which could serve as a novel therapeutic 
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